Skip to main content
. Author manuscript; available in PMC: 2015 Oct 7.
Published in final edited form as: J Am Coll Surg. 2013 Oct 24;218(2):196–205. doi: 10.1016/j.jamcollsurg.2013.10.011

Table 2.

Details of Liver-Directed Procedure among Patients with Fibrolamellar Carcinoma or Hepatocellular Carcinoma from 1998 to 2008

Variable FLC (n = 65) HCC (n = 6,311) p Value
Type of liver-directed procedure
 Surgery not otherwise specified <11 (<16.9) 50 (0.8) 0.230
 Ablative procedure only <11 (<16.9) 1,902 (30.1) <0.001
 Partial hepatectomy 16 (24.6) 1,197 (19.0) 0.250
 Minor hepatectomy 16 (24.6) 1,197 (19.0) 0.250
 Hemihepatectomy 24 (36.9) 1,021 (16.2) <0.001
 Extended hepatectomy (>5 segments) <11 (<16.9) 171 (2.7) <0.001
 Liver transplant <11 (<16.9) 1,970 (31.2) <0.001

Cells with fewer than 11 cases per variable cell were relabeled as <11 (<%) in compliance with the National Cancer Institute data-usage agreement for reporting of SEER data.

FLC, fibrolamellar carcinoma; HCC, hepatocellular carcinoma.